Core Insights - Oragenics, Inc. is advancing ONP-002, a novel intranasal neurosteroid, as a potential first pharmacological treatment for concussion and mild traumatic brain injury (mTBI) [1][3][11] - The company is well-prepared to initiate clinical site onboarding and first patient dosing in Australia for a Phase 2 clinical trial [1][2][8] Clinical Development - The Phase 2a clinical trial will evaluate 40 patients who meet specific enrollment criteria, with dosing occurring within 12 hours of concussion [10] - The trial aims to assess safety and tolerability through follow-up visits, including nasal examinations and neurocognitive testing [10] - Interim data from the Phase 2a trial is expected throughout 2026, with a final readout anticipated in Q4 2026 [8] Market Opportunity - The global concussion market is projected to exceed $9 billion by 2030, with ONP-002 positioned to be the first commercial treatment in this space [3][5] - The nasal drug delivery market is expected to reach nearly $93 billion by 2030, indicating significant potential for ONP-002 if approved [5] Financial Position - Oragenics raised $16.5 million through a public offering of Series H convertible preferred stock and warrants, supporting ongoing clinical development [8] - The company maintains a clean balance sheet with zero debt, fully funding the Phase 2a trial [8] Strategic Collaborations - A strategic collaboration has been formed with Receptor.AI to enhance drug discovery capabilities, potentially expanding the company's molecule portfolio beyond ONP-002 [8]

Core Insights - VenHub Global, Inc. is enhancing its technology innovation efforts in autonomous retail solutions with the appointment of Tarang Sethia as Executive Vice President of Product & Technology [1][2] Group 1: Management Changes - Tarang Sethia has been appointed to lead VenHub's product vision and technology platform, focusing on scalable systems to accelerate Smart Store growth and improve unit economics [2] - Sethia reports directly to the CEO, Shahan Ohanessian, and is expected to drive continuous innovation in the company's technology development [2][3] Group 2: Leadership Background - Sethia brings over 20 years of experience in product and technology leadership, having previously worked at bp and 7-Eleven, where he led significant retail technology transformations [3] - His expertise includes developing customer-centric digital products and scalable commercial solutions, which will be instrumental in VenHub's growth strategy [3][4] Group 3: Product and Technology Focus - VenHub's Smart Stores utilize robotics, automation, and mobile technology to provide a seamless, unattended shopping experience, operating 24/7 [4][5] - The stores are designed for secure operations and efficient transactions, catering to a wide range of consumer needs at any time of day [4]

Unaudited Financials Reflect $44.0M in Total Assets and $24.9M in Net AssetsSingapore, Feb. 09, 2026 (GLOBE NEWSWIRE) -- YY Group Holding Announces Total Assets and Net Assets per Share of $1.11 and $0.63, Respectively, as of June 30, 2025 Unaudited Financials Reflect $44.0M in Total Assets and $24.9M in Net Assets YY Group Holding Limited (NASDAQ: YYGH) (“YY Group” or the “Company”), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced that, as of Jun ...

LAS VEGAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- VenHub Global, Inc. (NASDAQ: VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today highlighted a recent addition to the senior management team that is helping to accelerate the Company’s technology innovation efforts focused on delivering a leading autonomous retail solution for communities and consumers. Tarang Sethia has been appointed Executive Vice President of Product & Technology, with primary responsibility for VenHu ...

Core Insights - Pelican Bay Capital Management (PBCM) reported a strong performance for its Concentrated Value Strategy, achieving an 8.5% return in Q4 2025, outperforming the Russell 1000 Value Index which returned 3.8% [1] - The full-year return for the Strategy was 20.6%, compared to 15.9% for the Index, driven by AI-related stocks and commodities exposure [1] Company Overview: AECOM (NYSE:ACM) - AECOM is highlighted as a new addition to PBCM's portfolio, recognized as the world's largest engineering, design, and construction management firm [2][3] - As of February 6, 2026, AECOM's stock closed at $101.03 per share, with a one-month return of 1.60% and a decline of 6.45% over the past twelve months [2] - AECOM has a market capitalization of $13.06 billion [2] Strategic Shift - AECOM has undergone a structural transformation over the past six years, divesting its construction operations and focusing on Design Engineering and Project Management, which reduces risks associated with large-scale project deadlines and budget overruns [3] Hedge Fund Interest - AECOM is not among the 30 most popular stocks among hedge funds, with 37 hedge fund portfolios holding the stock at the end of Q3 2025, down from 41 in the previous quarter [4] - While AECOM is recognized for its potential, PBCM suggests that certain AI stocks may offer greater upside potential and lower downside risk [4]

Silver price prediction futures: Silver entered 2026 with explosive momentum. In early January, spot $121 per ounce, marking an all-time high driven by macroeconomic anxiety, Federal Reserve uncertainty, and heavy retail investor participation. Futures data from COMEX showed record trading volumes, while silver-backed exchange-traded funds recorded their strongest inflows in years. That optimism unraveled abruptly on January 30, 2026, when silver prices fell more than 30% in a single session, wiping out wee ...

Albemarle Corporation (NYSE:ALB) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts. JPMorgan Lifts Albemarle Corporation (NYSE:ALB) Price Target as Lithium Sentiment Turns On January 28, JPMorgan analyst Jeffrey Zekauskas made a big adjustment to his outlook on Albemarle Corporation (NYSE:ALB), lifting his price recommendation to $195 from $80. The analyst maintained a Neutral rating on the stock. The move reflected how quickly sentiment around lithium has shifted after a long ...

Core Insights - Pelican Bay Capital Management (PBCM) reported a strong performance for its Concentrated Value Strategy, achieving an 8.5% return in Q4 2025, significantly outperforming the Russell 1000 Value Index, which returned 3.8% [1] - For the full year, PBCM's strategy yielded a 20.6% return compared to 15.9% for the Index, driven by AI-related stocks and commodities exposure [1] Company Overview - FactSet Research Systems Inc. (NYSE:FDS) was highlighted as a new addition to PBCM's portfolio, despite experiencing a one-month return of -30.18% and a 52-week loss of 55% [2] - As of February 6, 2026, FactSet's stock closed at $207.32 per share, with a market capitalization of $7.758 billion [2] Financial Performance - FactSet achieved $2.3 billion in revenue for fiscal year 2025, marking over 45 years of consecutive top-line growth [3] - The company maintains a high retention rate exceeding 95% and delivers high-teens returns on invested capital (ROIC) [3] - In the first quarter of fiscal 2026, FactSet generated $608 million in revenue, reflecting a year-over-year growth of 6.9% [4] Investment Considerations - While FactSet is recognized for its potential, PBCM suggests that certain AI stocks may offer greater upside potential with less downside risk [4]

CVS Health Corporation (NYSE:CVS) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts. JPMorgan Names CVS a Top Pick as Turnaround Gains Traction On January 28, Argus trimmed its price recommendation on CVS Health Corporation (NYSE:CVS) to $90 from $91. However, the firm maintained a Buy rating on the stock. The shares fell nearly 15% after the Centers for Medicare and Medicaid Services proposed keeping Medicare Advantage reimbursement rates flat for 2027 compared with 2026. Arg ...

Group 1 - Rubrik (RBRK) stock peaked at $97 per share in June 2025 but has since lost nearly 50% of its value, currently trading at $51 [1] - Amrita leads a boutique family office fund in Vancouver, focusing on sustainable, growth-driven companies to maximize shareholder equity [1] - The fund aims to democratize financial literacy and simplify complex macroeconomic concepts for better understanding [1] Group 2 - Amrita has a background in high-growth supply-chain start-ups and has worked with venture capital firms to enhance user acquisition [1] - Her newsletter, The Pragmatic Optimist, has been recognized as a top finance newsletter and focuses on portfolio strategy and valuation [1]